Watson Scores Win In J&J Patent Spat Over Concerta
Handing a win to Watson Pharmaceuticals Inc., a federal court has ruled that a Watson subsidiary's generic version of attention deficient disorder treatment Concerta would not infringe a patent asserted by...To view the full article, register now.
Already a subscriber? Click here to view full article